Population and Public Health

Michael Pace, founder and president of PalmHealthCo, highlights how his company advises organizations, including pharma, in commercialization and go-to-market strategies for digital therapeutics - and his experience at Pear Therapeutics.  

Eversana senior vice president of health innovation, Alberta Spreafico, discusses the company's collaboration with the Digital Therapeutics Alliance to analyze frameworks and map reimbursement pathways in Europe for digital health adoption.  

Gaurav Sharma, market innovator and global client partner at Cognizant, discusses the balance between accelerating healthcare's use of technology with putting regulations in place to protect patients.  

Digital therapeutics can improve health equity by empowering patients to adhere to medication intake, says Tanisha Hill, founder and president of the Digital Health for Equitable Health Alliance. Still, the digital divide needs to be addressed.  

Dr. Yusuf Sherwani, CEO and cofounder of Pelago, describes how the company partners with employers and health plans to control the costs of substance misuse disorders and the effectiveness of the virtual evidence-based treatment platform.  

Dr. Jeffrey Chen, clinical advisor at No Barrier AI, believes the company's AI medical interpreter app could improve outcomes for low-English-proficiency patients, prevent clinician burnout and reduce operational costs.  

Susan Conover, Piction Health CEO and cofounder, discusses the company's collaborations with dermatologists in 20 countries to build its AI to ensure accuracy across skin tones and the organization's objectives thanks to recent funding.  

SVP of advanced analytics Pravin Pant and associate VP of interoperability strategy Michael Gould, both at ZeOmega, discuss how providers should adopt FHIR standards to achieve TEFCA compliance and enable easier data sharing with payers.  

Oscar Alleyne, managing director of the public health division at MITRE, relays how federally funded research and development centers help public and private companies solve complex problems, including preparing for the next pandemic.  

In 2027, CMS will start rewarding MA plans that demonstrate progress in addressing health disparities, but they will need to measure performance ahead of that, explains Anna Basevich, SVP of enterprise partnerships and customer enablement at Arcadia.